# Medallion Financial Corp: financial statements, quarterly

MFIN · Nasdaq · CIK 1000209 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mfin.md) · [Financials](/companies/mfin/financials.md) · [Filings](/companies/mfin/filings.md) · [Insiders](/companies/mfin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mfin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [17.1](/filings/0000950170-23-059368.md) | [18.6 d](/filings/0000950170-24-027942.md) | [19.2](/filings/0000950170-24-054668.md) | [20.8](/filings/0000950170-24-092721.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.7](/filings/0000950170-24-122240.md) | [6.3 d](/filings/0001193125-26-100121.md) | [6.4](/filings/0000950170-25-064417.md) | [3.8](/filings/0000950170-25-103028.md) | [4.1](/filings/0001193125-25-264655.md) | [6.8 d](/filings/0001193125-26-100121.md) | [6.7](/filings/0001193125-26-206358.md) | [5.8](/filings/0001193125-26-335042.md) | [5.9](/filings/0001193125-25-264655.md) | [6.2 d](/filings/0001193125-26-100121.md) | [4.3](/filings/0001193125-26-206358.md) | [4.7](/filings/0001193125-26-335042.md) |
| Net income | $m | [11.2](/filings/0000950170-24-122240.md) | [14.3 d](/filings/0001193125-26-100121.md) | [10.0](/filings/0000950170-25-064417.md) | [7.1](/filings/0000950170-25-103028.md) | [8.6](/filings/0001193125-25-264655.md) | [10.1 d](/filings/0001193125-26-100121.md) | [12.0](/filings/0001193125-26-206358.md) | [11.1](/filings/0001193125-26-335042.md) | [7.8](/filings/0001193125-25-264655.md) | [12.2 d](/filings/0001193125-26-100121.md) | [5.0](/filings/0001193125-26-206358.md) | [7.4](/filings/0001193125-26-335042.md) |
| Diluted EPS | $ per share | [0.48](/filings/0000950170-24-122240.md) | not reported | [0.42](/filings/0000950170-25-064417.md) | [0.30](/filings/0000950170-25-103028.md) | [0.37](/filings/0001193125-25-264655.md) | not reported | [0.50](/filings/0001193125-26-206358.md) | [0.46](/filings/0001193125-26-335042.md) | [0.32](/filings/0001193125-25-264655.md) | not reported | [0.20](/filings/0001193125-26-206358.md) | [0.31](/filings/0001193125-26-335042.md) |
| Basic EPS | $ per share | [0.50](/filings/0000950170-24-122240.md) | not reported | [0.44](/filings/0000950170-25-064417.md) | [0.31](/filings/0000950170-25-103028.md) | [0.38](/filings/0001193125-25-264655.md) | not reported | [0.53](/filings/0001193125-26-206358.md) | [0.49](/filings/0001193125-26-335042.md) | [0.34](/filings/0001193125-25-264655.md) | not reported | [0.21](/filings/0001193125-26-206358.md) | [0.32](/filings/0001193125-26-335042.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.5](/filings/0000950170-23-059368.md) | [52.6](/filings/0000950170-25-038693.md) | [54.8](/filings/0000950170-24-054668.md) | [87.7](/filings/0000950170-24-092721.md) | [121](/filings/0000950170-24-122240.md) | [98.2](/filings/0001193125-26-100121.md) | [132](/filings/0000950170-25-064417.md) | [110](/filings/0000950170-25-103028.md) | [72.5](/filings/0001193125-25-264655.md) | [136](/filings/0001193125-26-335042.md) | [93.9](/filings/0001193125-26-206358.md) | [173](/filings/0001193125-26-335042.md) |
| Total assets | $m | [2,559](/filings/0000950170-24-122240.md) | [2,588](/filings/0001193125-26-100121.md) | [2,619](/filings/0000950170-25-064417.md) | [2,761](/filings/0000950170-25-103028.md) | [2,880](/filings/0001193125-25-264655.md) | [2,869](/filings/0001193125-26-100121.md) | [2,848](/filings/0001193125-26-206358.md) | [2,880](/filings/0001193125-26-335042.md) | [2,900](/filings/0001193125-25-264655.md) | [2,955](/filings/0001193125-26-335042.md) | [2,950](/filings/0001193125-26-206358.md) | [3,194](/filings/0001193125-26-335042.md) |
| Total liabilities | $m | [2,161](/filings/0000950170-23-059368.md) | [2,176](/filings/0000950170-25-038693.md) | [2,201](/filings/0000950170-24-054668.md) | [2,338](/filings/0000950170-24-092721.md) | [2,449](/filings/0000950170-24-122240.md) | [2,430](/filings/0001193125-26-100121.md) | [2,399](/filings/0000950170-25-064417.md) | [2,347](/filings/0000950170-25-103028.md) | [2,404](/filings/0001193125-25-264655.md) | [2,447](/filings/0001193125-26-335042.md) | [2,443](/filings/0001193125-26-206358.md) | [2,688](/filings/0001193125-26-335042.md) |
| Long-term debt | $m | [218](/filings/0000950170-23-059368.md) | [236](/filings/0000950170-25-038693.md) | [226](/filings/0000950170-24-054668.md) | [231](/filings/0000950170-24-092721.md) | [232](/filings/0000950170-24-122240.md) | [232](/filings/0001193125-26-100121.md) | [200](/filings/0000950170-25-064417.md) | [200](/filings/0000950170-25-103028.md) | [216](/filings/0001193125-25-264655.md) | [216](/filings/0001193125-26-335042.md) | [214](/filings/0001193125-26-206358.md) | [288](/filings/0001193125-26-335042.md) |
| Short-term borrowings | $m | [18.5](/filings/0000950170-23-059368.md) | [8.0](/filings/0000950170-25-038693.md) | [32.5](/filings/0000950170-24-054668.md) | [37.5](/filings/0000950170-24-092721.md) | [49.0](/filings/0000950170-24-122240.md) | [49.0](/filings/0001193125-26-100121.md) | [112](/filings/0000950170-25-064417.md) | [86.8](/filings/0000950170-25-103028.md) | [80.3](/filings/0001193125-25-264655.md) | [95.3](/filings/0001193125-26-335042.md) | [44.5](/filings/0001193125-26-206358.md) | [54.5](/filings/0001193125-26-335042.md) |
| Shareholders' equity | $m | [328](/filings/0000950170-23-059368.md) | [343](/filings/0000950170-25-038693.md) | [349](/filings/0000950170-24-054668.md) | [354](/filings/0000950170-24-092721.md) | [362](/filings/0000950170-24-122240.md) | [370](/filings/0001193125-26-100121.md) | [380](/filings/0000950170-25-064417.md) | [390](/filings/0000950170-25-103028.md) | [397](/filings/0001193125-25-264655.md) | [409](/filings/0001193125-26-335042.md) | [408](/filings/0001193125-26-206358.md) | [406](/filings/0001193125-26-335042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.9 d](/filings/0000950170-24-122240.md) | [19.6 d](/filings/0001193125-26-100121.md) | [32.3](/filings/0000950170-25-064417.md) | [27.6 d](/filings/0000950170-25-103028.md) | [24.6 d](/filings/0001193125-25-264655.md) | [24.2 d](/filings/0001193125-26-100121.md) | [33.1](/filings/0001193125-26-206358.md) | [(23.0) d](/filings/0001193125-26-335042.md) | [82.3 d](/filings/0001193125-25-264655.md) | [33.8 d](/filings/0001193125-26-100121.md) | [41.3](/filings/0001193125-26-206358.md) | [17.5 d](/filings/0001193125-26-335042.md) |
| Dividends paid | $m | [1.8 d](/filings/0000950170-24-122240.md) | [2.2 d](/filings/0001193125-26-100121.md) | [2.5](/filings/0000950170-25-064417.md) | [2.2 d](/filings/0000950170-25-103028.md) | [2.2 d](/filings/0001193125-25-264655.md) | [2.4 d](/filings/0001193125-26-100121.md) | [2.9](/filings/0001193125-26-206358.md) | [2.7 d](/filings/0001193125-26-335042.md) | [2.7 d](/filings/0001193125-25-264655.md) | [2.7 d](/filings/0001193125-26-100121.md) | [3.1](/filings/0001193125-26-206358.md) | [3.2 d](/filings/0001193125-26-335042.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122240.md) | [0.0 d](/filings/0001193125-26-100121.md) | [2.1](/filings/0000950170-25-064417.md) | [1.5 d](/filings/0000950170-25-103028.md) | [1.0 d](/filings/0001193125-25-264655.md) | [0.0 d](/filings/0001193125-26-100121.md) | [0.5](/filings/0001193125-26-206358.md) | [0.5 d](/filings/0001193125-26-335042.md) | [0.0 d](/filings/0001193125-25-264655.md) | [0.0 d](/filings/0001193125-26-100121.md) | [0.0](/filings/0001193125-26-206358.md) | [7.7 d](/filings/0001193125-26-335042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.5](/filings/0000950170-23-059368.md) | [23.0](/filings/0000950170-24-054668.md) | [22.9](/filings/0000950170-24-092721.md) | [23.4](/filings/0000950170-24-122240.md) | [23.8](/filings/0000950170-25-064417.md) | [23.5](/filings/0000950170-25-103028.md) | [23.4](/filings/0001193125-25-264655.md) | [23.9](/filings/0001193125-26-206358.md) | [24.1](/filings/0001193125-26-335042.md) | [24.4](/filings/0001193125-25-264655.md) | [24.5](/filings/0001193125-26-206358.md) | [24.0](/filings/0001193125-26-335042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,960,249 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.